sk&f-38393 has been researched along with Hypertrophy in 3 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nickla, DL | 1 |
| Totonelly, K | 1 |
| Dhillon, B | 1 |
| Yasunari, K | 2 |
| Kohno, M | 2 |
| Kano, H | 2 |
| Yokokawa, K | 1 |
| Minami, M | 2 |
| Yoshikawa, J | 2 |
| Hanehira, T | 1 |
1 review available for sk&f-38393 and Hypertrophy
| Article | Year |
|---|---|
Anti-atherosclerotic action of vascular D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arteriosclerosis; Cell Division | 1999 |
2 other studies available for sk&f-38393 and Hypertrophy
| Article | Year |
|---|---|
Dopaminergic agonists that result in ocular growth inhibition also elicit transient increases in choroidal thickness in chicks.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Apomorphine; | 2010 |
Dopamine D1-like receptor stimulation inhibits hypertrophy induced by platelet-derived growth factor in cultured rat renal vascular smooth muscle cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Bromo Cyclic Adenosine Monophosphate; | 1997 |